Home

Current Product Focus

During the next 12 months Braasch is focused on specific new vaccine products that address problems in:

Human Health

  • Human Obesity and Diabetes Obesity
  • Growth Hormone Deficiencies in Children - such as Idiopathic / Short Stature, Turner's Syndromes
  • IGF-1 Responsive Neurological Disorders - such as Rett's Syndrome (female autism)

Animal Health

  • Livestock Productivity:
    • SomatovacTM Dairy Vaccine - to improve milk productivity in dairy cows.
    • SomatovacTMSwine Vaccine - to improve feed efficiency and daily gain in pigs.

  • Companion Animal Obesity:
    • Canine Obesity Vaccine - for treatment and control of Obesity in Dogs.
    • Feline Obesity Vaccine - for treatment and control of Obesity in Cats.

"To date, we have established proof-of-concept in independent mice obesity models and in livestock productivity and growth studies."

Copyright © 2010 Braasch Biotech LLC. All rights reserved.
Webmaster

News and Releases


August 31, 2009

  • New Braasch Biotech Vaccine Technology Provides Growth Hormone and IGF-1 Treatments without the use of drugs


  • New Braasch Biotech Vaccine Technology Promises Greater Livestock Productivity and Obesity Treatment without drugs